More concrete evidence the legal cannabis industry is growing by leaps and bounds; Jacksonville, Fla-based mCig, Inc. (OTC:MCIG) announced that the nutraceutical joint venture of the Company and BRRx Clinical Inc. is set to move forward with a letter of intent to supply a national independent compounding pharmacy network.
BRRx Clinical will begin releasing the CBD-enhanced medical foods/topical applications that are in FDA trials. The products are registered with the International Review Board. The first of these offerings will be for the treatment of shingles.
Said MCIG CEO Paul Rosenberg,“(BBRx) completely changed my view on the whole cannabis industry and the steps the Company should take in order to stay ahead of its competitors. In a few weeks, we are going to introduce our revolutionary BRRx Clinical web portal, which will allow the Company to offer some unique products that will change the lives of millions of people.”
MCIG shares leaped 28.2% to four cents, on volume of 3.8 million shares.
